492 related articles for article (PubMed ID: 21480103)
1. Furazolidone, amoxicillin and omeprazole with or without bismuth for eradication of Helicobacter pylori in peptic ulcer disease.
Ghadir MR; Shafaghi A; Iranikhah A; Pakdin A; Joukar F; Mansour-Ghanaei F
Turk J Gastroenterol; 2011 Feb; 22(1):1-5. PubMed ID: 21480103
[TBL] [Abstract][Full Text] [Related]
2. Furazolidone-based, metronidazole-based, or a combination regimen for eradication of Helicobacter pylori in peptic ulcer disease.
Khatibian M; Ajvadi Y; Nasseri-Moghaddam S; Ebrahimi-Dariani N; Vahedi H; Zendehdel N; Sotoudehmanesh R; Agah S; Mikaeli J; Pourshams A; Ali-Asgari A; Malekzadeh R; Massarrat S
Arch Iran Med; 2007 Apr; 10(2):161-7. PubMed ID: 17367217
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
Park KN; Hahm JS; Kim HJ
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
[TBL] [Abstract][Full Text] [Related]
4. Quadruple therapy with furazolidone for retreatment in patients with peptic ulcer disease.
Felga GE; Silva FM; Barbuti RC; Navarro-Rodriguez T; Zaterka S; Eisig JN
World J Gastroenterol; 2008 Oct; 14(40):6224-7. PubMed ID: 18985815
[TBL] [Abstract][Full Text] [Related]
5. Low-dose furazolidone in triple and quadruple regimens for Helicobacter pylori eradication.
Fakheri H; Merat S; Hosseini V; Malekzadeh R
Aliment Pharmacol Ther; 2004 Jan; 19(1):89-93. PubMed ID: 14687170
[TBL] [Abstract][Full Text] [Related]
6. Low dose furazolidone for eradication of H- pylori instead of clarithromycin: a clinical trial.
Hajaghamohammadi A; Safiabadi Tali SH; Samimi R; Oveisi S; Kazemifar AM
Glob J Health Sci; 2014 Aug; 7(1):235-9. PubMed ID: 25560342
[TBL] [Abstract][Full Text] [Related]
7. Randomized clinical trial comparing two one-week triple-therapy regimens for the eradication of Helicobacter pylori infection and duodenal ulcer healing.
Forné M; Viver JM; Esteve M; Fernández-Bañares F; Lite J; Espinós JC; Quintana S; Salas A; Garau J
Am J Gastroenterol; 1998 Jan; 93(1):35-8. PubMed ID: 9448170
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the efficacy and safety of the hybrid scheme for eradication therapy of Helicobacter pylori infection.
Yurenev GL; Partzvania-Vinogradova EV; Andreev DN; Dicheva DT; Maiev IV
Ter Arkh; 2018 Aug; 90(8):33-39. PubMed ID: 30701937
[TBL] [Abstract][Full Text] [Related]
9. Omeprazole plus amoxicillin versus triple therapy eradicates Helicobacter pylori in the Chinese with peptic ulcer disease.
Wang K; Lin HJ; Chua RT; Perng CL; Tsay SH; Lee SD
Zhonghua Yi Xue Za Zhi (Taipei); 1996 Mar; 57(3):184-90. PubMed ID: 8935224
[TBL] [Abstract][Full Text] [Related]
10. One-week omeprazole, furazolidone and amoxicillin rescue therapy after failure of Helicobacter pylori eradication with standard triple therapies.
Wong WM; Wong BC; Lu H; Gu Q; Yin Y; Wang WH; Fung FM; Lai KC; Xia HH; Xiao SD; Lam SK
Aliment Pharmacol Ther; 2002 Apr; 16(4):793-8. PubMed ID: 11929398
[TBL] [Abstract][Full Text] [Related]
11. Short-duration furazolidone therapy in combination with amoxicillin, bismuth subcitrate, and omeprazole for eradication of Helicobacter pylori.
Hasan SR; Vahid V; Reza PM; Roham SR
Saudi J Gastroenterol; 2010; 16(1):14-8. PubMed ID: 20065568
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of ranitidine bismuth citrate plus amoxycillin and clarithromycin as first- or second-line therapy to cure Helicobacter pylori infection.
Tursi A; Brandimarte G; Giorgetti G; Modeo ME; Gigliobianco A
Hepatogastroenterology; 2002; 49(46):1006-9. PubMed ID: 12143188
[TBL] [Abstract][Full Text] [Related]
13. High efficacy of 14-day triple therapy-based, bismuth-containing quadruple therapy for initial Helicobacter pylori eradication.
Sun Q; Liang X; Zheng Q; Liu W; Xiao S; Gu W; Lu H
Helicobacter; 2010 Jun; 15(3):233-8. PubMed ID: 20557366
[TBL] [Abstract][Full Text] [Related]
14. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
Laine L; Estrada R; Trujillo M; Emami S
Am J Gastroenterol; 1997 Dec; 92(12):2213-5. PubMed ID: 9399755
[TBL] [Abstract][Full Text] [Related]
15. Efficacies of different proton pump inhibitor-based 14-day bismuth-furazolidone quadruple regimens for the initial eradication of Helicobacter pylori in the southeast coastal region of China: an open-label, randomized clinical trial.
Chen L; He J; Wang L; Ge Q; Chu H; Chen Y; Chen X; Long Y; Deng Y; He H; Li A; Chen S
Clin Exp Med; 2018 Nov; 18(4):569-576. PubMed ID: 29876770
[TBL] [Abstract][Full Text] [Related]
16. [Effect of birid triple viable on peptic ulcer patients with Helicobacter pylori infection].
Xu C; Xiao L; Zou H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Sep; 35(9):1000-4. PubMed ID: 20871168
[TBL] [Abstract][Full Text] [Related]
17. To compare the efficacy of triple therapy with furazolidone, amoxicillin and omeprazole for two weeks and three weeks in the eradication of Helicobacter pylori in Bangladeshi duodenal ulcer patients.
Saha SK; Saha SK; Masud H; Islam N; Raihan AS; Roy PK; Hasan M
Bangladesh Med Res Counc Bull; 2011 Dec; 37(3):83-7. PubMed ID: 22352226
[TBL] [Abstract][Full Text] [Related]
18. Dual versus triple therapy: comparison of five antibiotic regimens for eradication of Helicobacter pylori in a prospective, randomized study.
Kirstein FW; Epple HJ; Bojarski C; Victor L; Fromm M; Riecken EO; Schulzke JD
Z Gastroenterol; 1998 Sep; 36(9):803-9. PubMed ID: 9795409
[TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori eradication in childhood after failure of initial treatment: advantage of quadruple therapy with nifuratel to furazolidone.
Nijevitch AA; Shcherbakov PL; Sataev VU; Khasanov RSh; Al Khashash R; Tuygunov MM
Aliment Pharmacol Ther; 2005 Nov; 22(9):881-7. PubMed ID: 16225499
[TBL] [Abstract][Full Text] [Related]
20. Two-day quadruple therapy for cure of Helicobacter pylori infection: a comparative, randomized trial.
Calvet X; García N; Campo R; Brullet E; Comet R; Navarro M
Am J Gastroenterol; 1998 Jun; 93(6):932-4. PubMed ID: 9647022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
